Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
Visit: http://www.melogia.com
Buy: https://itunes.apple.com/us/artist/sarantos/id784136489?ign-mpt=uo%3D4
Song: "I'd Give Anything" - "This is a harsh rock song about a desperate man who remembers the love he used to have," says Sarantos. "He would give anything for his heart to be happy." Sarantos strives to inspire people with his rock songs and lyrics. Music is always on his mind and Sarantos has written over 2,000 songs. Sarantos' music has received rave reviews so far from industry insiders, and he relishes this chance to pursue his lifelong dream. His unique sound has been best described by industry insiders as "An emotionally powerful vocal style masterfully united with music that is a fusion of classic 80s rock blended with modern soft rock and pop music!"
A new music song will be released the 1st Tuesday of every month to tease his fans. Then a new music video on the 2nd Tuesday of every month, a new Funny video of the month on the 3rd Tuesday of every month and a new Whiteboard video on the 4th Tuesday of every month. This will go on for the entire year! The CD will then be released on November 18th, 2014.
Sarantos has always been inclined to help people in need and is proud to launch this CD as a way to donate a significant portion of proceeds to charity, hopefully inspiring other artists to do the same. The 11 charities chosen for each album song include American Lung Association, Make-a-wish Foundation, American Heart Association, St Jude's, Hellenic Academy, ASERF, American Red Cross, Children's Hospital of Chicago, Chicago Medical School, Thanioton Society & the Cystic Fibrosis Foundation.
Conntect With Sarantos On Facebook:
https://www.facebook.com/Sarantosmelogia
Connect With Sarantos On Twitter:
http://www.twitter.com/sarantosmelogia
http://www.charity4couture.com Hello
Lovelies! I’m Nancy Li, founder of Charity4Couture; a nonprofit
organization that takes donated clothes, refurbishes them (such as
studding, cutting, sewing, etc.), and then sells them on my website.
Best of all, proceeds will be donated directly to St.Jude\\\'s Research
Hospital and the Hirshberg Foundation.
http://www.indiegogo.com/fundcharity4couture
OhioHealth Riverside Methodist Hospital is now treating patients with peripheral artery disease (PAD) with the first drug-eluting stent to be used outside of the heart. Cook Medical’s Zilver PTX is a drug-coated stent that is used to reopen a long thigh artery, located above the knee (the femoropopliteal artery), narrowed or blocked due to PAD. This is the most common artery for PAD blockages.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60291-ohiohealth-riverside-hospital-zilver-ptx-drug-coated-stent-for-pad
In response to the growing need for quality healthcare in Chicago, Northwestern Medicine is proud to announce the opening of a new, one-million square foot outpatient pavilion at 259 E. Erie St. The new pavilion opened on Oct. 13 in the heart of Northwestern Medicine’s downtown medical campus, home to Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7049451-northwestern-medicine-to-open-259-east-erie-patient-pavilion-in-october/
St. Jude Children’s Research Hospital, www.stjude.org, announced today the appointment of James R. Downing, M.D., as its new CEO, effective July 15, 2014. Downing most recently has served as the Deputy Director, Executive Vice President and Scientific Director of the hospital, which is leading the way the world understands, treats and defeats pediatric cancer and other catastrophic diseases. Downing’s primary focus immediately upon assuming the CEO office will be to oversee a new era of clinical, research and infrastructure expansion throughout the St. Jude global network. He succeeds Dr. William E. Evans, who is retiring from the position after 10 years and returning full time to his long-standing pharmacogenomics research program at St. Jude.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7256651-st-jude-children-s-research-hospital-new-era-of-expansion-and-growth/
This week Hill-Rom (NYSE: HRC) is featuring the Progressa® bed system, the next generation of intensive care unit (ICU) bed systems, at the American Organization of Nurse Executives (AONE) annual meeting in Orlando, Fla. The Progressa bed system is a therapeutic system designed to treat and prevent complications of immobility. It features a state-of-the-art design that supports treatment goals and was engineered to help address patient migration via its StayInPlace™ technology.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/66137-hill-rom-new-progressa-bed-system
A level IV trauma center in Washington State has installed copper components throughout its facility as another way of reducing hospital-acquired infections and keeping their patients safe.
Pullman Regional Hospital has become an early adopter of antimicrobial copper after studies found that the age-old metal could continuously kill deadly bacteria.
Each year, 2 million people in the United States are diagnosed with a hospital-acquired infection and nearly 100,000 people die. These infections are caused by common bacteria such as E. coli, MRSA, C. diff, CRE and VRE.
“It is a very serious problem,” said Ed Harrich, the director of surgical services for Pullman Regional Hospital. “I think every hospital across the nation is doing everything they can to try to deal with it the best that they can. But there’s bioburden on everything and people aren’t good at hand washing and there’s cross-contamination everywhere you go.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378651-copper-development-association-cda-pullman-regional-hospital-keep-patients-safe-antimicrobial-copper/
Orbis, the international nonprofit that unites the world in the fight against blindness, is proud to land its new, state-of-the-art Flying Eye Hospital in Shenyang, China this week to commence its first training program, running from September 5 - 23. Six years in the making, the third-generation Flying Eye Hospital is the world’s only mobile ophthalmic teaching hospital on board an MD-10 aircraft, donated by FedEx. Hundreds of experts have come together to combine the latest in avionics, hospital engineering, technology and clinical expertise to make the new Flying Eye Hospital a reality. It features modular design, 3D technology and live broadcast capabilities, which enables Orbis and their expert Volunteer Faculty to train more doctors, nurses and healthcare professionals—ultimately treating more people and restoring their sight.
“Today, I am incredibly proud that our Flying Eye Hospital can get to work on its first program,” Bob Ranck, Orbis CEO and President, said. “It is a testament to the hundreds of volunteers, global corporate partners, governments and other individuals who have worked tirelessly to make this unique aircraft a reality, and we thank them one and all. Our mission at Orbis is to bring the world together to fight blindness, and the Flying Eye Hospital is an important tool for achieving this. It is an equal-parts teacher, envoy and advocate for the right to sight. We are excited to start this new chapter in Orbis history here in Shenyang, China.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7316251-orbis-flying-eye-hospital/
Hospital-acquired infections can be deadly – and many times preventable. Nearly every major public health organization agrees that ineffective “hand-hygiene” (hand washing or using disinfecting sprays, wipes or gels) is one of the most significant contributors to the problem. Further compounding the problem is the fact that compliance rates among caregivers are difficult to track and often found to be low.
Hill-Rom has developed a new system to help hospitals monitor hand-hygiene rates: the Hill-Rom® Hand Hygiene Compliance Solution. The new offering, which is now available to hospitals nationwide, provides real-time monitoring and staff reminders, simplifies reporting, and can use the same hardware and devices as other Hill-Rom real-time locating solutions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61990-hill-rom-launches-new-hospital-hand-hygiene-monitoring-solution
The Perelman School of Medicine at the University of Pennsylvania and the March of Dimes Foundation announce the launch of a new $10 million Prematurity Research Center here.
The March of Dimes will invest $10 million during the next five years to create a transdisciplinary center conducting team-based research, led by physicians and researchers at the Hospital of the University of Pennsylvania and The Children’s Hospital of Philadelphia, to discover the unknown causes of preterm birth and develop new strategies to prevent it. This March of Dimes Prematurity Research Center at the University of Pennsylvania is part of a “medical Manhattan Project” of five such centers in the United States created by the foundation since 2011.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/65164-march-of-dimes-march-for-babies-2014/
St. Jude Children’s Research Hospital®, uno de los principales centros de investigación y tratamiento del cáncer pediátrico se unió a Univision Radio, la mayor difusora de radio Hispana en los Estados Unidos, para realizar su evento radial anual Promesa y Esperanza®. Los radioyentes alrededor del país sintonizaron su estación favorita de Univision Radio el 7 y 8 de febrero y recaudaron más de $5.3 millones en efectivo y promesas monetarias. Los fondos recaudados ayudarán a cubrir los gastos de investigación y tratamiento del cáncer pediátrico y otras enfermedades terminales en los Estados Unidos, Puerto Rico y alrededor del mundo.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58260-st-jude-childrens-research-hospital-univision-radio-promesa-y-esperanza
